The influence of cerebral 5-hydroxytryptamine on catalepsy induced by brain-amine depleting neuroleptics or by cholinomimetics

British Journal of Pharmacology
L D Fuenmayor, M Vogt


1 Catalepsy was produced in rats and mice by the subcutaneous injection of either tetrabenazine or the butyrophenone U-32,802A (4'-fluoro-4-{[4-(p-fluorophenyl)-3-cyclohexen-1-yl]amino} butyrophenone hydrochloride). Catalepsy was evaluated by the duration of total immobility on a vertical grid.2 Pretreatment with p-chlorophenylalanine (PCPA) reduced the intensity of catalepsy by 50% or more, whereas its time course remained the same.3 5-Hydroxytryptophan (5-HTP), 10 mg/kg, enhanced the catalepsy induced by U-32,802A or tetrabenazine, provided it was administered soon (45 min) after the neuroleptic; injections at 90 min had no effect. Otherwise untreated rats given this dose of 5-HTP behaved normally on the grid.4 The anticataleptic effect of PCPA was reversed by 5-HTP.5 Measurable changes in 5-hydroxytryptamine (5-HT) metabolism in the rat forebrain accompanied the modification of catalepsy by 5-HTP and PCPA.6 Methysergide (5 mg/kg) given 30 min before the neuroleptics to either mice or rats reduced the catalepsy, assessed 2.5 h after the methysergide. It also prevented the increase in neuroleptic-induced catalepsy following 5-HTP, 10 mg/kg.7 Tryptophan, like 5-HTP, increased the catalepsy seen in mice after U-32,802A and tetra...Continue Reading


Jul 25, 1975·Brain Research·R J BaldessariniS Gerson
Jan 1, 1975·Pharmacology, Biochemistry, and Behavior·J MajB Przewlocka
Nov 1, 1975·Neuropharmacology·B CostallC Pycock
Jan 1, 1973·Pharmacology·W GumulkaA Czlonkowski
Jun 15, 1974·Biochemical Pharmacology·R A Lahti, D Lednicer
Feb 1, 1970·British Journal of Pharmacology·R O'KeeffeM Vogt
Sep 28, 1954·The Journal of Physiology·W FELDBERG, S L SHERWOOD


Dec 27, 1995·European Journal of Pharmacology·M L Wadenberg, S Ahlenius
Jan 1, 1996·Neuroscience and Biobehavioral Reviews·M L Wadenberg
Mar 1, 1985·Journal of Neurochemistry·L D Fuenmayor, M Bermúdez
Nov 26, 2016·International Journal of Molecular Sciences·Danilo De GregorioGabriella Gobbi
Sep 1, 1982·Annals of Neurology·I S LoginR M MacLeod
Jan 1, 1984·Psychopharmacology·P R SanbergJ T Coyle
Jun 1, 1981·The Journal of Pharmacy and Pharmacology·J J BalsaraA G Chandorkar

Related Concepts

Atropine Sulfate Anhydrous
Biogenic Amines
Brain Chemistry
Waxy Flexibility
Antispasmodic Effect
Parasympathomimetic Effect
Antipsychotic Effect

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here